Apply on Employer Site

Glaukos Corporation · 19 hours ago

Area Director (iBM West)

Los Angeles, CA, United States

Full-time

Onsite

Director/Executive

$155K/yr - $202K/yr

10+ years exp

Glaukos Corporation is seeking an Interventional Business Manager (iBM) Director to lead a high-performing field team focused on driving growth in the interventional glaucoma portfolio. The role is essential for achieving revenue targets and shaping regional business strategy while fostering collaboration across various departments.

Health CareMedicalWellness

Growth Opportunities

Responsibilities

Lead, coach, and develop the iBM team to achieve and exceed area sales goals

Recruit, onboard, and retain top field talent

Partner with Area and Regional Directors to align strategic priorities and execution plans

Support field effectiveness through co-travel, performance coaching, and best-practice sharing

Build and maintain strong relationships with KOLs and key accounts

Oversee training and development on business reviews, practice onboarding, and customer engagement

Identify and address market dynamics, competitive activity, and business opportunities

Qualification

Sales experienceOphthalmology knowledgeLeadership experienceCRM proficiencyBusiness planningCoaching skillsExcel proficiencyPowerPoint proficiencyCommunication skills

Required

Bachelor's Degree required; advanced degree preferred

10+ years of sales or marketing experience, ideally within ophthalmology or medical devices

Proven leadership experience managing field teams with strong results

Solid understanding of reimbursement, practice integration, and surgical sales

Excellent communication, business planning, and coaching skills

Proficiency with CRM tools (SFDC), Excel, and PowerPoint

Preferred

advanced degree preferred

Benefits

Variable Incentive/Bonus

RSUs

Company

Glaukos Corporation

At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

Founded in 1998

San Clemente, California, USA

1001-5000 employees

http://www.glaukos.com

Funding

Current Stage

Public Company

Total Funding

$121M

Key Investors

Meritech Capital PartnersOrbiMed

2015-06-25IPO

2013-02-07Series F· $30M

2012-10-03Debt Financing· $6M

Leadership Team

Alex Thurman

Senior Vice President and Chief Financial Officer

Joseph Gilliam

President & Chief Operating Officer

Recent News

Orange County Business Journal

Midday Stock Roundup: Shimmick Drops on Low Volume

2026-01-24

Orange County Business Journal

Do Not Use

2026-01-22

BioSpace

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance

2026-01-16

Company data provided by crunchbase